Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toxic heavy metal ions, such as arsenic, cadmium, lead, and mercury, are non-essential elements that can accumulate within the tumor microenvironment (TME) due to environmental exposure or metabolic dysfunction. These ions are recognized as potent carcinogens that promote tumor development and progression by inducing chronic oxidative stress and generating reactive oxygen species (ROS) [1][2]. In the TME, they disrupt genomic stability by causing direct DNA damage and inhibiting essential DNA repair enzymes, such as those involved in nucleotide excision repair [3]. Additionally, heavy metals can alter cellular signaling pathways and epigenetic patterns, contributing to the epithelial-to-mesenchymal transition (EMT) and enhanced metastatic potential [4]. While they are not traditional biological targets like receptors or enzymes, they are the focus of therapeutic interventions using chelating agents, which bind the ions to facilitate their excretion, and emerging nanoparticle-based sequestration strategies [5]. Managing the levels of these metals is critical, as their presence in the TME is associated with increased malignancy and resistance to conventional therapies [6].
Chelation of metal ions to form stable, water-soluble complexes for renal or fecal excretion; Sequestration via functionalized nanoparticles to prevent biological interaction within the tumor microenvironment.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toxic heavy metal ions.